Search CORE

7 research outputs found

Ketanserin as an ocular hypotensive agent

Author: COSTAGLIOLA C
FASANO ML
FERRARA LIBERATO ALDO
IULIANO G
KETANSERIN AS AN OCULAR HYPOTENSIVE AGENT
MASTROPASQUA L.
MENZIONE M
SCIBELLI G
Publication venue: Altier Maynard Communications:59 Oakwood Drive:Madison, CT 06443:(203)421-3494, Fax: (203)421-3250
Publication date: 01/01/1993
Field of study

Archivio della ricerca - Università degli studi di Napoli Federico II

Intermittent claudication incites systemic neutrophil activation and increased vascular permeability

Author: Anner
Blixt
Dawson
Hickey
Hickey
Hickey
Hudlicka
Kling
Miller
O'Riordan
Persson
Prevention of Atherosclerotic Complications with Ketanserin (PACK) Trial Group
Reed
Schmid-Shonbein
Shearman
Stringer
Suval
Welbourn
Williams
Zeintl
Publication venue: 'Wiley'
Publication date
Field of study

Effects of R-102444, an orally active 5-HT2A receptor antagonist, in rat models of peripheral vascular disease

Author: Ashida
Banga
Barradas
Cohen
De Clerck
De Clerck
De Cree
Hara
Hiatt
Hirsch
Lehert
Lund
Motoyama
Murai
Murakami
Ogawa
Orlandi
PACK Claudication Substudy
Prevention of Atherosclerotic Complications with Ketanserin Trial Group
Qi
Rydzewski
Schmieder
Sharma
Smith
Tanaka
Turpie
Vanhoutte
Verheyen
Wakitani
Zander
Zehender
Publication venue: 'Elsevier BV'
Publication date
Field of study

Effects of Ketanserin on Lipids, Lipoproteins, and Plasma Atrial Natriuretic Factor in Patients with Essential Hypertension

Author: Ames
Benarroch
Beretta-Piccoli
Burnett
Cantin
Chalmers
Copeland
Donkier
Doorenbos
Genest
Grundy
Gutkowska
Hedner
Keller
Leysen
Lussier-Cacan
MacMahon
Mann
Mauersberger
Nakamura
Nueten
Persson
Pirola
Prevention of Atherosclerotic Complications with Ketanserin Trial Group
Richards
Sagnella
Singh
Sniderman
Sniderman
Stott
Sugawara
Symoens
Teng
Wing
Zachariah
Publication venue: 'Wiley'
Publication date
Field of study

The role of serotonin in cardiovascular diseases and their treatment

Author: A Holmsen
CN Gillis
F Clerck De
G Engel
G. J. Blauw
GA Head
GJ Blauw
GJ Blauw
GJ Blauw
GJ Blauw
HO Kalkman
IH Page
J Holtz
J Roose De
JE Leijsen
JM Nueten Van
JM Nueten Van
K Jie
L Finch
M Göthert
M Göthert
M Tada
ML Cohen
N Fetkovska
O Codella
OK Roald
P Golino
P. A. van Zwieten
P. van Brummelen
PA Zwieten Van
PA Zwieten Van
PM Vanhoutte
PM Vanhoutte
PM Vanhoutte
PM Vanhoutte
PM Vanhoutte
PPA Humphrey
Prevention of atherosclerotic complications with Ketanserin Trial Group
R Amstein
W Klein
W Schoetensack
Publication venue: 'Springer Science and Business Media LLC'
Publication date
Field of study

Pharmacology of antihypertensive agents with multiple actions

Author: A Breckenridge
A Salvetti
A Semplicini
AM Huchet
B Lantz
BNC Prichard
BNC Prichard
BNC Prichard
D Cambridge
F Paillard
G Allan
G Gross
GJ Blauw
GJ Blauw
ID Dukes
IW Copeland
JIS Robertson
JL Reid
JM Nueten Van
JR Fozard
K Strein
Ketanserin Trial Group
KH Rahn
L Hansson
M Beaufils
M Laubi
M Leeman
ME Cook
N Kolassa
P. A. van Zwieten
PA Zwieten Van
PA Zwieten Van
PA Zwieten Van
PA Zwieten Van
PA Zwieten Van
PM Vanhoutte
RA Gillis
RD Smith
RJ Gordon
RW Watkins
S Sundberg
SR O'Donnell
T Baum
T Baum
TJ Verbeuren
TP Pruss
U Abshagen
W Schoetensack
WJ Louis
Publication venue: 'Springer Science and Business Media LLC'
Publication date
Field of study

Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin.

Author: Adt M
Ahlman H
Amout J
Anger C
Anger C
Arneklo-Nobin B
Ball SG
Barvais L
Bazan A
Bellucci S
Beretta-Piccoli C
Biondi ML
Blauw GJ
Boddeke HWGM
Breckenridge A
Cadranel J
Cameron HA
Cameron HA
Cashman JN
Castaner M
Chalmers JP
Corea L
Cressman DO
De Alberdi ZS
De Crte J
De Lorenzo A
De Lorenzo A
De Nicola P
Di Lorenzo M
Di Veroli C
Diemer HP
Docherty JR.
Dona G
Douglas WW
Doyle AE
Dragona A
Eccles NK
Erspamer V
Forst R
Gerritsen HA
Gordin A
Hamet A
Hedner T
Hedrter T
Heistad DD
Heistad DD
Helmers JHJH
Heykants J
Hollenberg NK
Hosie J
Huet Y
Jacobs MJHM
Janssens M
Jennings AA
Kamiya K
Kane JA
Ketanserin
Kirch W
Kubo T
Leysen JE
Lijnen P
Lijnen P
Lijnen P
Lueben V
Mauersberger H
McCormack PME
McGoon MD
McGrath JC
Milei J
Milei J
Miranda DR
Nalda MA
Navis G
Nevelsteen A
Oestergren J
Ohnhaus EE
Palermo A
Peroutka SJ
Persson B
Petralito A
Ponz L
Raffestin B
Ramage AG
Reimann IW
Robertson JIS
Rocco A
Rocco A
Rocco S
Rosendorff C
Rosendorff C
Rosenthal J
Rucquoi M
Sanchez RA
Santini P
Saraste K
Schalekamp MADH
Seedat YK
Seibold JR
Serafin R
Singh BN
Spaeth P
Stott DJ
Stott DJ
Strano A
Symoens J
Timmermans PBMWM
Tomlinson IW
Tomlinson IW
Tooke JE
Trenk D
Tuncer M
Van de Wai HJCM
Van Den Broeke JJW
Van Der Linden MMD
Van der Starre PJA
Van der Starre PJA
Van der Starre PJA
Van Nueten JM
Van Nueten JM
Van Nueten JM
Van Nueten JM
Vanhoutte PM
Vanhoutte PM
Verheyen A
Williams BC
Wing LMH
Zahorsky R
Publication venue: 'Ovid Technologies (Wolters Kluwer Health)'
Publication date
Field of study

core

core